[1]
|
Moffat, D.A., Hardy, D.G. and Bagueley, D.M. (1989) Strategy and Benefits of Acoustic Neuroma Searching. The Journal of Laryngology & Otology, 103, 51-59. http://dx.doi.org/10.1017/S0022215100108023
|
[2]
|
Tos, M., Charabi, S. and Thomsen, J. (1999) Incidence of Vestibular Schwannomas. Laryngoscope, 109, 736-740.
http://dx.doi.org/10.1097/00005537-199905000-00011
|
[3]
|
Rouleau, G.A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) Alteration in a New Gene Encoding a Putative Membrane-Organizing Protein Causes Neurofibromatois Type 2. Nature, 363, 515-521. http://dx.doi.org/10.1038/363515a0
|
[4]
|
Trofatter, J.A., MacCollin, M.M., Rutter, J.L., Murrell, J.R., Duyao, M.P., Parry, D.M., Eldridge, R., Kley, N., Menon, A.G., Pulaski, K., et al. (1993) A Novel Moesin-, Ezrin-, Radixin-Like Gene Is a Candidate for the Neurofibromatosis 2 Tumor Suppressor. Cell, 72, 791-800. http://dx.doi.org/10.1016/0092-8674(93)90406-G
|
[5]
|
Irving, R.M., Moffat, D., Hardy, D.G., Barton, D.E., Xuereb, J.H. and Maher, E.R. (1994) Somatic NF2 Gene Mutations in Familial and Non-Familial Vestibular Schwannoma. Human Molecular Genetics, 3, 347-350.
http://dx.doi.org/10.1093/hmg/3.2.347
|
[6]
|
Lanser, M.J., Sussman, S.A. and Frazer, K. (1992) Epidemiology, Pathogenesis and Genetics of Acoustic Tumors. Otolaryngol Clin North Am, 25, 499-520.
|
[7]
|
Bederson, J.B., von Ammon, K., Wichmann, W.W. and Yasargil, M.G. (1991) Conservative Treatment of Patients with Acoustic Tumors. Neurosurgery, 28, 646-651. http://dx.doi.org/10.1227/00006123-199105000-00002
|
[8]
|
Sterkers, O., El Dine, M.B., Martin, N., Viala, P. and Sterkers, J.M. (1991) Slow versus Rapid Growth in Acoustic Neuromas. In: Tos, M. and Thomsen, J., Eds., Proceedings of the First International Conference on Acoustic Neuroma, Kugler Publications, Amsterdam, 3-6.
|
[9]
|
Nedzelski, J.M., Schessel, D.A., Pfleiderer, A., Kassel, E.E. and Rowed, D.W. (1992) Conservative Management of Acoustic Neuromas. Otolaryngol Clin North Amer, 25, 691-705.
|
[10]
|
Wazen, J., Silverstein, H., Norrell, H. and Besse, B. (1985) Preoperative and Postoperative Growth Rates in Acoustic Neuromas Documented with CT Scanning. Otolaryngology—Head and Neck Surgery, 93, 151-155.
|
[11]
|
Silverstein, H., McDaniel, A., Norrell, H. and Wazen, J. (1985) Conservative Management of Acoustic Neuroma in the Elderly Patient. Laryngoscope, 95, 766-770. http://dx.doi.org/10.1288/00005537-198507000-00002
|
[12]
|
Clark, W.C., Moretz, W.H., Acker, J.D., Gardner, L.G., Eggers, F. and Robertson, J.H. (1985) Nonsurgical Management of Small and Intracanalicular Acoustic Tumors. Neurosurgery, 16, 801-803.
http://dx.doi.org/10.1227/00006123-198506000-00011
|
[13]
|
Mautner, V.F., Baser, M.E., Thakker, S.D., Feiger, U.M., Freidman, J.M. and Kluwe, L. (2002) Vestibular Schwannoma Growth in Patients with Neurofibromatosis Type 2: A Longitudinal Study. Journal of Neurosurgery, 96, 223-228.
http://dx.doi.org/10.3171/jns.2002.96.2.0223
|
[14]
|
Baser, M.E., Makariou, E.V. and Parry, D.M. (2002) Predictors of Vestibular Schwannoma Growth in Patients with Neurofibromatosis Type 2. Journal of Neurosurgery, 96, 217-222. http://dx.doi.org/10.3171/jns.2002.96.2.0217
|
[15]
|
Antinheimo, J., Haapasalo, H., Sepp?la, M., Sainio, M., Carpen, O. and J??skenl?inen, J. (1995) Proliferative Potential of Sporadic and Neurofibromatosis 2-Associated Schwannomas as Studied by MIB-1 (Ki-67) and PCNA Labeling. Journal of Neuropathology and Experimental Neurology, 54, 776-782.
http://dx.doi.org/10.1097/00005072-199511000-00004
|
[16]
|
Sobel, R.A. (1993) Vestibular (Acoustic) Schwannomas: Histologic Features in Neurofibromatosis 2 and in Unilateral Cases. Journal of Neuropathology and Experimental Neurology, 52, 106-113.
http://dx.doi.org/10.1097/00005072-199303000-00002
|
[17]
|
Wu, C.L., Tahkker, N., Neary, W., Black, G., Lye, R., Ramsden, R.T., Read, A.P. and Evans, D.G. (1998) Differential Diagnosis of Type 2 Neurofibromatosis: Molecular Discrimination of NF2 and Sporadic Vestibular Schwannomas. Journal of Medical Genetics, 35, 973-977. http://dx.doi.org/10.1136/jmg.35.12.973
|
[18]
|
Hsu, S.M., Raine, L. and Fanger, H. (1981) The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase Technics. American Journal of Clinical Pathology, 75, 816-821.
|
[19]
|
Jacoby, L.B., MacCollin, M.M., Louis, D.N., Mohney, T., Rubio, M.P., Pulaski, K., Trofatter, J.A., Kley, N., Seizinger, B. and Ramesh, V. (1994) Exon Scanning for Mutation of the NF2 Gene in Schwannomas. Human Molecular Genetics, 3, 413-419. http://dx.doi.org/10.1093/hmg/3.3.413
|
[20]
|
Mohyuddin, A., Neary, W.J., Wallace, A., Wu, C.L., Read, A., Ramsden, R.T. and Evans, D.G.R. (2002) Molecular Genetic Analysis of the NF2 Gene in Young Patients with Unilateral Vestibular Schwannomas. Journal of Medical Genetics, 39, 315-322. http://dx.doi.org/10.1136/jmg.39.5.315
|
[21]
|
Wallace, A.J. (1997) Combined Single Strand Conformation Polymorphism and Heteroduplex Analysis. In: Taylor, G.R., Ed., Laboratory Methods for the Detection of Mutations and Polymorphism in DNA, CRC Press, Boca Raton, 79-94.
|
[22]
|
Weissenbach, J. (1993) A Second Generation Linkage Map of the Human Genome Based on Highly Informative Microsatellite Loci. Gene, 135, 275-278. http://dx.doi.org/10.1016/0378-1119(93)90077-G
|
[23]
|
Bourn, D. and Strachan, T. (1995) Highly Polymorphic Dinucleotide Repeat at the NF2 Gene. Human Genetics, 95, 712. http://dx.doi.org/10.1007/BF00209494
|
[24]
|
Marineau, C., Baron, C., Delattre, O., Zucman, J., Thomas, G. and Rouleau, G.A. (1993) Dinucleotide Repeat Polymorphism at the D22S268 Locus. Human Molecular Genetics, 2, 336. http://dx.doi.org/10.1093/hmg/2.3.336-a
|
[25]
|
Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J. (1994) The 1993-94 Genethon Human Genetic Linkage Map. Nature Genetics, 7, 246-339.
http://dx.doi.org/10.1038/ng0694supp-246
|
[26]
|
Schuler, G.D., Boguski, M.S., Stewart, E.A., Stein, L.D., Gyapay, G., Rice, K., White, R.E., Rodriguez-Tome, P., Aggarwal, A., Bajorek, E., Bentolila, S., Birren, B.B., Butler, A., Castle, A.B., Chiannikulchai, N., Chu, A., Clee, C., Cowles, S., Day, P.J., Dibling, T., Drouot, N., Dunham, I., Duprat, S., East, C. and Hudson, T.J. (1996) A Gene Map of the Human Genome. Science, 274, 540-546. http://dx.doi.org/10.1126/science.274.5287.540
|
[27]
|
Rubin, K., Tingstrom, A., Hansson, G.K., Larsson, E., Ronnstrand, L., Klareskog, L., Claesson-Welsh, L., Heldin, C.H., Fellstrom, B. and Terracio, L. (1988) Induction of B-Type Receptors for Platelet-Derived Growth Factor in Vascular Inflammation: Possible Implications for Development of Vascular Proliferative Lesions. The Lancet, 1, 1353-1356. http://dx.doi.org/10.1016/S0140-6736(88)92177-0
|
[28]
|
Fajardo, L.F., Kwan, H.H., Kowalski, J., Prionas, S.D. and Allison, A.C. (1992) Dual Role of Tumor Necrosis Factor-Alpha in Angiogenesis. The American Journal of Pathology, 140, 539-544.
|
[29]
|
Weerda, H.G., Gamberger, T.I., Siegner, A., Gjuric, M. and Tamm, E.R. (1998) Effects of Transforming Growth Factor-Beta1 and Basic Fibroblast Growth Factor on Proliferation of Cell Cultures Derived from Human Vestibular Nerve Schwannoma. Acta Oto-Laryngologica, 118, 337-343. http://dx.doi.org/10.1080/00016489850183412
|
[30]
|
Gerdes, J., Lemke, H., Baisch, H., Wacker, H.H., Schwab, U. and Stein, H. (1984) Cell Cycle Analysis of a Cell Proliferation-Associated Human Nuclear Antigen Defined by the Monoclonal Antibody Ki-67. The Journal of Immunology, 133, 1710-1715.
|
[31]
|
Charabi, S., Engel, P., Jacobson, G.K., Tos, M. and Thomsen, J. (1993) Growth Rate of Acoustic Neuroma Expressed by Ki-67 Nuclear Antigen versus Symptom Duration. Annals of Otology, Rhinology & Laryngology, 102, 805-809.
http://dx.doi.org/10.1177/000348949310201013
|
[32]
|
Charabi, S., Engel, P., Charabi, B., Jacobsen, G.K., Overgaard, J., Thomsen, J. and Tos, M. (1996) Growth of Vestibular Schwannomas: In Situ Model Employing the Monoclonal Antibody Ki-67 and DNA Flow Cytometry. American Journal of Otolaryngology, 17, 301-306.
|
[33]
|
Lottrich, M., Mawrin, C., Chamaon, K., Kirches, E., Dietzmann, K. and Freigang, B. (2007) Expression of Transforming Growth Factor-β Receptor Type 1 and 2 in Human Sporadic Vestibular Schwannoma. Pathology—Research and Practice, 203, 245-249. http://dx.doi.org/10.1016/j.prp.2006.12.007
|
[34]
|
Irving, R.M., Harada, T., Moffat, D.A., Hardy, D.G., Whittaker, J.L., Xuereb, J.H. and Maher, E.R. (1997) Somatic Neurofibromatosis Type 2 Gene Mutations and Growth Characteristics in Vestibular Schwannoma. American Journal of Otolaryngology, 18, 754-760.
|
[35]
|
MacCollin, M.M., Ramesh, V., Jacoby, L.B., Louis, D.N., Rubio, M.P., Pulaski, K., Trofatter, J.A., Short, M.P., Bove, C. and Eldridge, R. (1994) Mutational Analysis of Patients with Neurofibromatosis 2. The American Journal of Human Genetics, 55, 314-320.
|
[36]
|
Gutmann, D.H., Hirbe, A.C. and Haipek, C.A. (2001) Functional Analysis of Neurofibromatosis 2 (NF2) Missense Mutations. Human Molecular Genetics, 10, 1519-1529. http://dx.doi.org/10.1093/hmg/10.14.1519
|
[37]
|
Kino, T., Takeshima, H., Nakao, M., Nishi, T., Yamamoto, K., Kimura, T., Saito, Y., Kochi, M., Kuratsu, J., Saya, H. and Ushio, Y. (2001) Identification of the Cis-Acting Region in the NF2 Gene Promoter as a Potential Target for Mutation and Methylation-Dependent Silencing in Schwannoma. Gene Cells, 6, 441-454.
http://dx.doi.org/10.1046/j.1365-2443.2001.00432.x
|